Sun Pharmaceuticals

Ranbaxy follows Sun Pharma in demerging R&D business

By | 19 Oct 2007

US FDA approves Sun Pharmaceutical'' version of Novartis''s Trileptal tablets for US sales

By | 10 Oct 2007

Impressive results by Sun Pharma

By Our Corporate Bureau | 31 Oct 2005

Sun Pharma to buy manufacturing site in Hungary

By Our Corporate Bureau | 11 Aug 2005

Sun Pharma to issue $75 million FCCB

By Our Corporate Bureau | 06 Dec 2004

Sun Pharma launches $225 million FCCB

By Our Corporate Bureau | 19 Nov 2004

Sun Pharmaceuticals proposes share swap with Phlox Pharma

By Our Corporate Bureau | 03 Aug 2004

Sun Pharma plants get US regulatory clearance

By Our Corporate Bureau | 28 May 2004

Two Sun Pharma units gets USFDA approval

By Our Corporate Bureau | 27 May 2004

Sun Pharma increases holding in Caraco

By Our Corporate Bureau | 16 Mar 2004

Sun Pharma to increase holdings in Caraco to 60 per cent

By Our Corporate Bureau | 09 Feb 2004

Sun Pharma logs healthy growth

By Venkatachari Jagannathan | 03 Feb 2004

Sun Pharmaceuticals approves resolutions for split, buyback

By Our Corporate Bureau | 21 Dec 2002

Sun Pharma clocks 12% turnover, 14% PAT increase in Q2

By Our Corporate Bureau | 29 Oct 2002

DCI team clears Sun Pharma research facility

By Venkatachari Jagannathan | 18 Sep 2002

Sun Pharma sales, profit up; dividend at 50%

By Venkatachari Jagannathan | 01 Jun 2002

Sun Pharma meet on merger with MJ Pharma

By Venkatachari Jagannathan | 27 May 2002

Sun Pharma commissions Dadra plant

30 Mar 2002

Caraco gets FDA nod for a drug

By September 2001, the interest payout | 09 Jan 2002

Explosion at Sun Pharma lab

08 Jan 2002

Sildenafil citrate drug sales surge

By Praveen Chandran | 05 Dec 2001

Sun Pharma launches cure for smoking

By Venkatachari Jagannathan | 14 Aug 2001

Will the ‘Sun’ rise on Caraco Pharmaceuticals?

By Venkatachari Jagannathan | 10 Apr 2001

Sun Pharma announces 1:500 share swap for Pradeep Drugs

By The board of directors of Mumbai-based Sun Pharmac | 27 Feb 2001

Sun Pharma plans to take over Pradeep Drugs

By The Mumbai-based, Rs.476-crore turnover pharma maj | 16 Feb 2001